Skip to content

Effect of Apamarga Kshara Malahara Application in Children with Fungal Infection

"An Open Labelled Controlled Comparative Clinical Study to Evaluate the Efficacy of Apamarga Kshara Malahara in Dadru W.S.R to Tinea".

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061148
Enrollment
100
Registered
2024-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Apamarga Kshara Malahara: Apamarga Kshara Malahara external application 2 times daily for 7 days Control Intervention1: Terbinafine ointment: Terbinafine ointment application 2 times da

Sponsors

Dr Akshay Gurav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patients with classical lakshanas of Dadru irrespective of chronicity will be selected. Patients of either sex Age group between 5-15 years will be included. Both fresh and treated cases of Dadru will be selected.

Exclusion criteria

Exclusion criteria: Patients with known cases of systemic disorders like juvenile diabetes mellitus, auto immune diseases, etc., which interferes with the course of the treatment, will be excluded. Tinea associated with secondary infection and other skin diseases will be excluded.

Design outcomes

Primary

MeasureTime frame
Improvements in the Signs and Symptoms of Dadru- Kandu ( Itching ) Raga ( Erythema ) Pidaka ( Eruption ) Daha ( Burning sensation ) Rookshata ( Dryness ) Udgata mandala ( Elevated lesion ) Timepoint: Before and after 7 days of Treatment

Secondary

MeasureTime frame
Improvement in the Assessment criteriaTimepoint: Before & After 7 days of Intervention

Countries

India

Contacts

Public ContactDr Akshay Gurav

Parul Institute of Ayurveda

sunilchangle16@gmail.com9687613916

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026